tiprankstipranks
Kairos Pharma, Ltd. (KAPA)
:KAPA
US Market

Kairos Pharma, Ltd. (KAPA) Stock News & Sentiment

138 Followers
Expanding Lung Cancer Franchise and Strategic Asset Acquisition Support Buy Rating on Kairos Pharma
Premium
Ratings
Expanding Lung Cancer Franchise and Strategic Asset Acquisition Support Buy Rating on Kairos Pharma
1M ago
Kairos Pharma Acquires Rights to AI-Discovered EGFR Therapy
Premium
Company Announcements
Kairos Pharma Acquires Rights to AI-Discovered EGFR Therapy
1M ago
Kairos Pharma Expands Lung Cancer Pipeline With Celyn Deal
Premium
Company Announcements
Kairos Pharma Expands Lung Cancer Pipeline With Celyn Deal
2M ago
Kairos Pharma’s Promising Clinical Developments and Strategic Focus Drive Buy Rating
Premium
Ratings
Kairos Pharma’s Promising Clinical Developments and Strategic Focus Drive Buy Rating
5M ago
Kairos Pharma Approves RSUs and Cash Bonuses
Premium
Company Announcements
Kairos Pharma Approves RSUs and Cash Bonuses
6M ago
Promising Developments in Kairos Pharma’s Lead Candidate ENV-105 Drive Buy Rating
Premium
Ratings
Promising Developments in Kairos Pharma’s Lead Candidate ENV-105 Drive Buy Rating
6M ago
Kairos Pharma to Present at ESMO Congress 2025
Premium
Company Announcements
Kairos Pharma to Present at ESMO Congress 2025
6M ago
More KAPA News >

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is KAPA’s Media Buzz Sentiment?
Currently, no data Available
What is KAPA’s weekly average amount of articles?
Currently, no data Available
What is KAPA’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
STAAStaar Surgical
IVVDInvivyd
SLPSimulations Plus
REPLReplimune Group
Showing the stocks with the most bullish news sentiment over the past week